Allergen-specific subcutaneous immunotherapy–pain evaluation in pediatric age

Main Article Content

Christiana Ferreira
Isabel Rezende
Arminda Guilherme
Inês Lopes

Keywords

Pain, allergen-specific subcutaneous immunotherapy, allergic pediatrics patients.

Abstract

Background: Allergen-specific immunotherapy is a potentially disease-modifying therapy that is effective for the treatment of patients with allergic diseases. Although the pain caused by the administration of subcutaneous immunotherapy with allergens (SCITA) is considered to be minimal, no studies assessing that pain for the treatment of only pediatric patients have been reported. Objectives: This research aimed to evaluate the pain associated with SCITA for pediatric patients followed at our Immunoallergology Department.



Methods: During four consecutive weeks, the nurse who administered the injection completed a questionnaire recording the child’s assessment of the pain associated with SCITA; these questionnaires were randomized before any analyses were done. Two different pain evaluation scales were used, with the choice of scale being determined based on the child’s age: the self-reporting faces scale (score: 0–10; 5 to 8 years old) and the numeric scale (score: 0–10; >8 years old). Demographic and clinical data, as well as any adverse reactions, were documented.


Results: We included 46 pediatric patients (mean age: 12.3 ± 2.6 years; 69.5% male), most of whom were suffering from rhinitis/rhinoconjunctivitis and undergoing subcutaneous immunotherapy with mites. Seven local adverse reactions were recorded, and all were mild. Ten patients did not mention any pain associated with SCITA. Of the 36 patients who mentioned some pain, 33 mentioned mild pain (scores between 1 and 3); only three mentioned moderate pain (scores between 4 and 6). For both scales, the median score obtained was 1. The maximum pain reported had a score of 6. No significant differences were observed between different groups of patients.


Conclusions: In this study, SCITA was shown to be a mildly painful procedure that is associated with only a few local reactions. Therefore, SCITA should be considered as a safe option for the treatment of most pediatric patients suffering from allergies.

Abstract 39 | PDF Downloads 18 XML Downloads 0 HTML Downloads 0

References

1. Dhami S, Nurmatov U, Arasi S, Khan T, Asaria M, Zaman H, et al. Allergen immunotherapy for allergic rhinoconjunctivitis: a systematic review and meta-analysis. Allergy. 2017;72:1597– 1631. https://doi.org/10.1111/all.13201

2. Durham R, Penagos M. Sublingual or subcutaneous immunotherapy for allergic rhinitis? J Allergy Clin Immunol. 2016;137(2):339. e10–349.e10. https://doi.org/10.1016/j.jaci.2015.12.1298

3. Kristiansen M, Dhami S, Netuveli G, Halken S, Muraro A, Roberts G, et al. Allergen immunotherapy for the prevention of allergy: a systematic review and meta-analysis. Pediatr Allergy Immunol. 2017;28:18–29. https://doi.org/10.1111/pai.12661

4. Breivik H. International Association for the Study of Pain: update on WHO-IASP activities. J Pain Symptom Manag. 2002;24(2):97–101. https://doi.org/10.1023/A:1013810912609

5. Montalvo A, Martín S, Mesa A, Cortés C, Rodríguez M, Laso MT. Comparative study of 3 types of lancets for performing prick tests. Allergol Immunopathol (Madr). 1996;24:58–64.

6. Abu-Saad H, Hamers H. Decision-making and paediatric pain: a review. J Adv Nurs. 1997;26(5):946–952. https://doi. org/10.1046/j.1365-2648.1997.00416.x

7. Von Baeyer CL. Children’s self-report of pain intensity: what we know, where we are headed. Pain Res Manag. 2009;14:39– 45. https://doi.org/10.1155/2009/259759

8. Von Baeyer CL. Children’s self-reports of pain intensity: scale selection, limitations and interpretation. Pain Res Manag. 2006;11:157–162. https://doi.org/10.1155/2006/197616

9. Sastre MT, Albaret MC, Escursell R, Mullet E. Fear of pain associated with medical procedures and illnesses. Eur J Pain. 2006;10:57–66. https://doi.org/10.1016/j.ejpain.2005.01.009

10. Spínola MA, Cosme J, Fernandes M, Machado C, Resende A, Pereira Barbosa M. Intensity of pain associated with subcutaneous administration of allergen immunotherapy. Rev Port Imunoalergologia. 2018;26:35–46.

11. Coop C, Forester J. Comparison of pain during skin-prick testing, immunizations, and phlebotomy. Allergy Asthma Proc. 2016;37:93–97. https://doi.org/10.2500/aap.2016.37.3961

12. Inal S, Kelleci M. Relief of pain during blood specimen collection in pediatric patients. Am J Matern Child Nurs. 2012;37:339– 345. https://doi.org/10.1097/NMC.0b013e31825a8aa5

13. Inal S, Kelleci M. Distracting children during blood draw: looking through distraction cards is effective in pain relief of children during blood draw. Int J Nurs Pract. 2012;18:210– 219. https://doi.org/10.1111/j.1440-172X.2012.02016.x

14. Baxter L, Cohen L, McElvery L, Lawson L, von Baeyer L. An integration of vibration and cold relieves venipuncture pain in a pediatric emergency department. Pediatr Emerg Care. 2011;27:1151–1156. https://doi.org/10.1097/PEC. 0b013e318237ace4

15. Uman S, Birnie A, Noel M, Parker A, Chambers T, McGrath J, et al. Psychological interventions for needle-related procedural pain and distress in children and adolescents. Cochrane Database Syst Rev. 2013;10:CD005179. https://doi.org/10.1002/14651858.CD005179.pub3

16. Koller D, Goldman D. Distraction techniques for children undergoing procedures: a critical review of pediatric research. J Pediatr Nurs. 2012;27:652–681. https://doi.org/10.1016/j.pedn. 2011.08.001

17. Jeffs A. A pilot study of distraction for adolescents during allergy testing. J Spec Pediatr Nurs. 2007;12:170–185. https:// doi.org/10.1111/j.1478-5153.2007.00220_1.x

18. Rodriguez P, Vidal C, Just J, Tabar AI, Sanchez-Machin I, Eberle P, et al. The European survey on adverse systemic reactions in allergen immunotherapy (EASSI): a pediatric assessment. Pediatr Allergy Immunol. 2017;28:60–70. https:// doi.org/10.1111/pai.12660